ArticleCell cycle (Georgetown, Tex.)2014

miR-221/222 control luminal breast cancer tumor progression by regulating different targets.

Patrizia Dentelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.